Doing few things and doing them well

Care/of
Earned
Tend
Orchard

What We Do

We believe in the power of doing few things and doing them well

We believe in the power of doing few things and doing them well

Juxtapose invests in technology businesses and platforms developed and greenlit at the firm.
‍‍
Our investment process starts with rigorous, multi-year concept development work that leverages our dedicated capabilities around commercial and industry diligence, user and ethnographic research, product and business design, corporate and business development, and capital markets experience.

We partner each greenlit opportunity with a world-class CEO that can launch, and scale, the business. We remain a deeply active partner to the founding CEO and team as the company grows and evolves.

Our raison d'être: to work on transformative products, in the most impactful industries, with the best entrepreneurial operators. We have a portfolio that is small in number, but transformative in impact.

Our Portfolio

Big industries meet even bigger talent.

Big industries meet even bigger talent.

Chris Johnson

CEO
Transforming healthcare for vulnerable populations

We partnered with Chris to bring healthcare services to underserved markets left behind by today’s healthcare system. Corduroy’s value-based contracting model helps it deliver positive outcomes while simultaneously delighting providers and the communities they serve. Chris has an incredible depth of experience in value-based healthcare, most recently as the CEO of Landmark Health, which Optum acquired in 2021. He specializes in bringing modern technology and data science to clinical organizations, ultimately aligning incentives for payors, providers and patients.

What got me excited
“I’ve had the privilege to spend my career serving vulnerable people on our communities. There is a shocking lack of access to primary care in low income neighborhoods - we are building a mission aligned provider organization, powered by data and technology, and enabled by value-based care to change that.”

Court Cunningham

CEO
Transforming life's most stressful transactiON

We partnered with Court to build a next-generation real estate platform that transforms the way everyday Americans buy and sell homes. Today, Orchard offers consumers AI-powered home discovery, on-demand purchasing so customers can buy a new home before selling their old home, and a modern digital closing—all for the same fee as traditional brokers. Court was previously the founding CEO of Yodle, where he took the company to over $200M in revenue and over 1,200 employees.

What got me excited
"Buying a home is the single biggest financial decisions of most consumers' lives. I found the opportunity to make this stress-free, fair and simple while transforming a $2 trillion market incredibly exciting."

Kristen Helton

CEO
Healthcare for women growing bolder

We partnered with Kristen to build an Advanced Primary Care platform focused on transforming the health and wellness paradigm for women 65+. We found that many women don't feel understood in the clinical setting, where their needs are overlooked, misunderstood and misdiagnosed. Kristen's experience in healthcare provided the best vantage point from which to build an omnichannel experience for them from the ground up, leveraging technology to deliver care in a value-based context. Kristen was previously the founding leader of Amazon Care, building a business serving hundreds of thousands of patient, and prior to that co-founded Profusa. Kristen is a trained scientist, having received a PhD in bioengineering.

What got me excited
"What excited me about the opportunity was the chance to design a healthcare experience for women 65+. Our focus on this demographic will allow us to craft a truly unique experience, and a value-based care reimbursement model incentives us to spend time on preventive health and wellness."

Juxtapose founding CEOs are proven entrepreneurial operators with track records spanning decades. We partner these CEOs and their co-founding leadership teams with ambitious, technology-driven transformation opportunities in large markets, with the aligned aim of building long-lasting businesses that move the world forward.

Our founding CEOs, by leveraging Juxtapose's years of pre-greenlight concept development work and in conjunction with our dedicated launch capabilities, are able to meaningfully accelerate their company's journey to scale and success. We consider our process to determine the right founding CEO the most important partnership decision we make as a fund, and the relationship most impactful to our long-term success.

Our companies and their founding teams are what define Juxtapose.

Foundational Beliefs

Our foundational beliefs shape how we build

The beliefs that shape how we build

[ 01 ]

We believe there is genuine power in choosing to focus on doing few things, and doing them well.

[ 02 ]

We believe in actively embracing the tensions inherent in doing things that are hard.

[ 03 ]

We believe that talent is truly everything. This extends from the Juxtapose team to our CEOs and their co-founders. We see all opportunities, whether in our portfolio, our firm, or the world at large, through a people-centric lens.

[ 04 ]

We believe in the power of virtuous alignment between our founders, our limited partners, the capital ecosystem, and our team. Individual greatness, only when properly harnessed for the good of the group, drives winning as a team.

Kristen Helton

"What excited me about the opportunity was the chance to design a healthcare experience for women 65+. Our focus on this demographic will allow us to craft a truly unique experience, and a value-based care reimbursement model incentives us to spend time on preventive health and wellness."

Company
Herself Health
Year Founded
2022
Industry
Healthcare
Healthcare for women growing bolder

We partnered with Kristen to build an Advanced Primary Care platform focused on transforming the health and wellness paradigm for women 65+. We found that many women don't feel understood in the clinical setting, where their needs are overlooked, misunderstood and misdiagnosed. Kristen's experience in healthcare provided the best vantage point from which to build an omnichannel experience for them from the ground up, leveraging technology to deliver care in a value-based context. Kristen was previously the founding leader of Amazon Care, building a business serving hundreds of thousands of patient, and prior to that co-founded Profusa. Kristen is a trained scientist, having received a PhD in bioengineering.

No items found.
Kristen before Herself Health

I've spent my career bridging technology to patient care. From clinical diagnostics and implantable biosensors, to telemedicine and connected devices, I bring a unique set of experiences to building modern, patient-focused healthcare delivery. Previously, I co-founded the biosensor company Profusa, as well as founded and led Amazon's first foray into healthcare services, Amazon Care. Amazon Care was designed to deliver convenient, patient-focused virtual and in-home healthcare. Care's on-demand service was built first for Amazon employees, and then expanded to serve other employers and their workforces. Under my leadership, Care grew from an idea, to virtual care in 50 states and in-home care in 15 cities with over 100k patients. Care boasted one of the highest ratings for healthcare services, with customer satisfaction at 4.7 out of 5 during my tenure. At the helm of Herself Health, I'm remaining focused on patient-centered, value-based care models that will drastically improve the patient experience and improve outcomes.

Career Highlights

2022

Introduced through Juxtapose to Julia Scully and members of the Project Sunrise team building out the first prototype for a woman-focused value based care platform. Spent time with Clay Richards and Michael Cline on how value-based care can transform women's health.

2017

Incepted and led Amazon Care, a hybrid virtual and in-home healthcare service. Prior to this, I served as a principal scientist at Amazon, where I assessed opportunities in healthcare, biotechnology, and related fields.

2010

Recognized as an inaugural UW Center for Commercialization (C4C) Fellow, where I developed the concept of a tissue-integrating biosensor. Several patents and the startup company, Profusa, were based on my research, and I served as co-founder, board member, and Chief Product Officer. Along with Dr. Wisniewski, I wrote and led grants totaling north of $20M to support the development and commercialization of the sensor platform.

2000

Developed the first point-of-care, real-time PCR instrument, the GeneXpert, while working as a systems integration engineer for startup Cepheid. I was instrumental in securing a $200M award from the USPS for rapid screening of bacillus anthracis in sorting facilities and other foundational work leading to Cepheid’s IPO in 2000.

Court Cunningham

"Buying a home is the single biggest financial decisions of most consumers' lives. I found the opportunity to make this stress-free, fair and simple while transforming a $2 trillion market incredibly exciting."

Company
Orchard
Year Founded
2017
Industry
Real Estate
Transforming life's most stressful transactiON

We partnered with Court to build a next-generation real estate platform that transforms the way everyday Americans buy and sell homes. Today, Orchard offers consumers AI-powered home discovery, on-demand purchasing so customers can buy a new home before selling their old home, and a modern digital closing—all for the same fee as traditional brokers. Court was previously the founding CEO of Yodle, where he took the company to over $200M in revenue and over 1,200 employees.

No items found.
Court before Orchard

I was previously the CEO of Yodle for 9 years, where I and the team grew the business from inception to over $200M in revenue and sold the business to Web.com in March 2016. Yodle was a leader in local online advertising that connected small businesses to consumers simply and cost-effectively through websites, SEO, email and SEM. Prior to Yodle, I was SVP of Marketing Automation at DoubleClick, where I built an industry-leading email marketing solution that was sold to Epsilon in 2005. I received an MBA from Harvard Business School in 1997 and a BA in English from Princeton University in 1991.

Career Highlights

2017

Met Phil DeGisi, my co-founder at Orchard, who has been the best business parter of my career with his grit, creativity and practicality.

2016

Sold Yodle to Web.com for $342M.

2000

Launched DartMail, one of the first email marketing platforms in the US, and scaled it to the de facto industry leader in 5 years.

1979

Met the woman who ultimately became my wife at her high school graduation (she was 18; I was 12...)

Related Articles
Chris Johnson

“I’ve had the privilege to spend my career serving vulnerable people on our communities. There is a shocking lack of access to primary care in low income neighborhoods - we are building a mission aligned provider organization, powered by data and technology, and enabled by value-based care to change that.”

Company
Corduroy
Year Founded
2023
Industry
Healthcare
Transforming healthcare for vulnerable populations

We partnered with Chris to bring healthcare services to underserved markets left behind by today’s healthcare system. Corduroy’s value-based contracting model helps it deliver positive outcomes while simultaneously delighting providers and the communities they serve. Chris has an incredible depth of experience in value-based healthcare, most recently as the CEO of Landmark Health, which Optum acquired in 2021. He specializes in bringing modern technology and data science to clinical organizations, ultimately aligning incentives for payors, providers and patients.

No items found.
Chris before Corduroy

Before founding Corduroy, I had the privilege of spending seven years at Landmark Health, which was a transformative career experience that opened my eyes to the scale that could be achieved in the value-based context. When I joined, I was energized by the challenge of expanding the business model the New England market and quickly realized how the business’s embrace of technology would enable us to grow rapidly while maintaining a high clinical and patient satisfaction bar. Landmark manages to make value-based care work in a way that is net positive for the world, and I was excited to leverage my experience for a new domain of care in pediatrics.

Career Highlights

2021

Elevated to CEO of Landmark Health after the Optum acquisition. Expanded Landmark from 12 to 38 states and quadrupled patients under management as Landmark became the cornerstone of Optum’s national in-home medical care strategy.

2017

Joined Landmark Health as vice president and GM responsible for launching the New England market.

2011

Co-founded Predilytics, which was a healthcare predictive analytics company focused on enabling payors and providers to leverage data to enable value-based care. Welltock acquired Predilytics in 2015.

2008

Started my career as a strategy consultant at Innosight, where I first gained my first exposure to the healthcare industry working under Clay Christensen.

Related Articles